Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many vaccines under development from sources other than Pfizer and Moderna the Government has on order; and how many of those on order he plans to distribute to the devolved nations.

The UK government has secured early access to 355 million vaccines doses through agreements with seven separate vaccine developers, which have been purchased for the whole of the UK. This includes agreements with:

• BioNTech/Pfizer for 40 million doses.
• Oxford/AstraZeneca for 100 million doses.
• GlaxoSmithKline and Sanofi Pasteur for 60 million doses.
• Novavax for 60 million doses.
• Janssen for 30 million doses.
• Valneva for 60 million doses.
• Moderna for 5 million doses.